{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T09:51:58Z","timestamp":1713347518491},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2007,10,10]],"date-time":"2007-10-10T00:00:00Z","timestamp":1191974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1007\/s00393-007-0215-z","type":"journal-article","created":{"date-parts":[[2007,10,9]],"date-time":"2007-10-09T02:20:30Z","timestamp":1191896430000},"page":"562-567","source":"Crossref","is-referenced-by-count":3,"title":["Neue Erkenntnisse zur Pathophysiologie und Therapie der Gicht","New knowledge on the pathophysiology and therapy of gout"],"prefix":"10.1007","volume":"66","author":[{"given":"A.","family":"So","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,10,10]]},"reference":[{"key":"215_CR1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.2004.024091","volume":"64","author":"Mikuls","year":"2005","unstructured":"Mikuls TR, Farrar JT, Bilker WB et al. (2005) Gout epidemiology: results from the UK General Practice Research Database, 1990\u20131999. Ann Rheum Dis 64: 267\u2013272","journal-title":"Ann Rheum Dis"},{"key":"215_CR2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.bor.0000209435.89720.7c","volume":"18","author":"Mikuls","year":"2006","unstructured":"Mikuls TR, Saag KG (2006) New insights into gout epidemiology. Curr Opin Rheumatol 18: 199\u2013203","journal-title":"Curr Opin Rheumatol"},{"key":"215_CR3","first-page":"1582","volume":"31","author":"Wallace","year":"2004","unstructured":"Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R (2004) Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 31: 1582\u20131587","journal-title":"J Rheumatol"},{"key":"215_CR4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S1726-4901(09)70320-X","volume":"69","author":"Lin","year":"2006","unstructured":"Lin SD, Tsai DH, Hsu SR (2006) Association between serum uric acid level and components of the metabolic syndrome. J Chin Med Assoc 69: 512\u2013516","journal-title":"J Chin Med Assoc"},{"key":"215_CR5","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1253\/circj.69.928","volume":"69","author":"Yoo","year":"2005","unstructured":"Yoo TW, Sung KC, Shin HS et al. (2005) Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 69: 928\u2013933","journal-title":"Circ J"},{"key":"215_CR6","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1681\/ASN.2005010063","volume":"16","author":"Johnson","year":"2005","unstructured":"Johnson RJ, Segal MS, Srinivas T et al. (2005) Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link? J Am Soc Nephrol 16: 1909\u20131919","journal-title":"J Am Soc Nephrol"},{"key":"215_CR7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11906-006-0005-z","volume":"8","author":"Feig","year":"2006","unstructured":"Feig DI, Kang DH, Nakagawa T et al. (2006) Uric acid and hypertension. Curr Hypertens Rep 8: 111\u2013115","journal-title":"Curr Hypertens Rep"},{"key":"215_CR8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/01.HYP.0000254480.64564.b6","volume":"49","author":"Krishnan","year":"2007","unstructured":"Krishnan E, Kwoh CK, Schumacher HR, Kuller L (2007) Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 49: 298\u2013303","journal-title":"Hypertension"},{"key":"215_CR9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.amjmed.2006.06.040","volume":"120","author":"Choi","year":"2007","unstructured":"Choi HK, Ford ES (2007) Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 120: 442\u2013447","journal-title":"Am J Med"},{"key":"215_CR10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/ncpneph0019","volume":"1","author":"Nakagawa","year":"2005","unstructured":"Nakagawa T, Tuttle KR, Short RA, Johnson RJ (2005) Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol 1: 80\u201386","journal-title":"Nat Clin Pract Nephrol"},{"key":"215_CR11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10157-005-0368-5","volume":"9","author":"Enomoto","year":"2005","unstructured":"Enomoto A, Endou H (2005) Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease. Clin Exp Nephrol 9: 195\u2013205","journal-title":"Clin Exp Nephrol"},{"key":"215_CR12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/BOR.0b013e328032781a","volume":"19","author":"Anzai","year":"2007","unstructured":"Anzai N, Kanai Y, Endou H (2007) New insights into renal transport of urate. Curr Opin Rheumatol 19: 151\u2013157","journal-title":"Curr Opin Rheumatol"},{"key":"215_CR13","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.lfs.2006.07.030","volume":"79","author":"Shima","year":"2006","unstructured":"Shima Y, Teruya K, Ohta H (2006) Association between intronic SNP in urate-anion exchanger gene, SLC22A12, and serum uric acid levels in Japanese. Life Sci 79: 2234\u20132237","journal-title":"Life Sci"},{"key":"215_CR14","doi-asserted-by":"crossref","unstructured":"Vazquez-Mellado J, Jimenez-Vaca AL, Cuevas-Covarrubias S et al. (2007) Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology (Oxford) 46: 215\u2013219","DOI":"10.1093\/rheumatology\/kel205"},{"key":"215_CR15","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.4049\/jimmunol.138.10.3213","volume":"138","author":"Di","year":"1987","unstructured":"Di Giovine FS, Malawista SE, Nuki G, Duff GW (1987) Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol 138: 3213\u20133218","journal-title":"J Immunol"},{"key":"215_CR16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","volume":"4","author":"Akira","year":"2004","unstructured":"Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4: 499\u2013511","journal-title":"Nat Rev Immunol"},{"key":"215_CR17","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/art.21238","volume":"52","author":"Liu-Bryan","year":"2005","unstructured":"Liu-Bryan R, Scott P, Sydlaske A et al. (2005) Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 52: 2936\u20132946","journal-title":"Arthritis Rheum"},{"key":"215_CR18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pharmthera.2003.08.003","volume":"100","author":"Fujihara","year":"2003","unstructured":"Fujihara M, Muroi M, Tanamoto K et al. (2003) Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol Ther 100: 171\u2013194","journal-title":"Pharmacol Ther"},{"key":"215_CR19","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.4049\/jimmunol.177.9.6370","volume":"177","author":"Scott","year":"2006","unstructured":"Scott P, Ma H, Viriyakosol S et al. (2006) Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals. J Immunol 177: 6370\u20136378","journal-title":"J Immunol"},{"key":"215_CR20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1074-7613(04)00046-9","volume":"20","author":"Agostini","year":"2004","unstructured":"Agostini L, Martinon F, Burns K et al. (2004) NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20: 319\u2013325","journal-title":"Immunity"},{"key":"215_CR21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/art.20033","volume":"50","author":"Hawkins","year":"2004","unstructured":"Hawkins PN, Lachmann HJ, Aganna E, McDermott MF (2004) Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 50: 607\u2013612","journal-title":"Arthritis Rheum"},{"key":"215_CR22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"Martinon","year":"2006","unstructured":"Martinon F, Petrilli V, Mayor A et al. (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237\u2013241","journal-title":"Nature"},{"key":"215_CR23","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1172\/JCI28075","volume":"116","author":"Chen","year":"2006","unstructured":"Chen CJ, Shi Y, Hearn A et al. (2006) MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J Clin Invest 116: 2262\u20132271","journal-title":"J Clin Invest"},{"key":"215_CR24","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2143","volume":"9","author":"So","year":"2007","unstructured":"So A, Desmedt T, Revaz S, Tschopp J (2007) A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 9: R28","journal-title":"Arthritis Res Ther"},{"key":"215_CR25","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","volume":"353","author":"Becker","year":"2005","unstructured":"Becker MA, Schumacher H R Jr, Wortmann RL et al. (2005) Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 353: 2450\u20132461","journal-title":"N Engl J Med"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-007-0215-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-007-0215-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-007-0215-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T10:24:17Z","timestamp":1684059857000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-007-0215-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,10]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["215"],"URL":"https:\/\/doi.org\/10.1007\/s00393-007-0215-z","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,10]]}}}